venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 6
- 0 vs. Q2 2024
- Portfolio value
- $194.3M
- −$37.2M (−16.1%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,289,304 | $79.4M | 40.9% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 2,826,048 | $30.2M | 15.5% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 614,594 | $24.6M | 12.7% | −420,802−40.6% | Reduced | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 1,519,971 | $23.5M | 12.1% | +1,519,971 | New | History |
| SLRNACELYRIN, Inc. | COM | 3,852,470 | $19.0M | 9.8% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $17.7M | 9.1% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (1)
Positions held at the end of Q2 2024 that are gone from this filing.